|
시장보고서
상품코드
2051217
탈모 치료 시장 : 약제 클래스별, 질환 유형별, 투여 경로별, 유통 채널별, 지역별Alopecia Treatment Market, By Drug Class, By Disease Type, By Route of Administration, By Distribution Channel, By geography |
||||||
탈모 치료 시장은 2026년에 113억 8,000만 달러로 추정되며, 2033년까지 168억 9,000만 달러에 이를 것으로 예상되고 있습니다. 또한 2026-2033년 CAGR 5.8%를 기록할 전망입니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도 : | 2025년 | 2026년 시장 규모 : | 113억 8,000만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간(2026-2033년) CAGR : | 5.80% | 2033년 시장 규모 예측 : | 168억 9,000만 달러 |
탈모증은 탈모의 의학 용어입니다. 탈모는 자연 현상으로 발생하기도 하고, 질병이나 특정 약물의 사용으로 인해 발생하기도 합니다. 일반적인 탈모증의 유형에는 다음과 같은 것들이 있습니다.
- 남성형 탈모증은 남성에게도 여성에게도 흔하게 나타납니다. 남성형 또는 여성형 탈모증이라고도 합니다.
- 원형탈모증은 반흔성 탈모증이라고도 합니다. 탈모반은 신체 어느 부위에나 나타날 수 있지만, 대부분의 사람들은 두피에 원형 또는 타원형의 탈모반이 발생합니다.
- 견인성 탈모증은 머리카락을 반복적으로 잡아당기거나 잡아당기는 행위로 인해 모발에 스트레스가 가해져 발생합니다.
시장 역학
시장 관계자들은 신제품 출시 및 승인에 집중하고 있으며, 이는 예측 기간 동안 세계 탈모증 치료제 시장의 성장을 견인할 것으로 예측됩니다. 예를 들어, 2022년 9월 Dr. Reddy's Laboratories Limited는 여성형 탈모증(FPHL) 치료제로 미녹시딜 외용액 USP 2%와 5%를 출시한다고 발표했습니다. Dr. Reddy's는 이들 제품을 각각 'Mintop 2%'와 'Mintop Eva 5%'로 판매할 예정입니다. 이번 출시는 인도 중앙의약품표준관리기구(CDSCO)가 여성형 탈모증(FPHL) 치료제로 미녹시딜 외용액 USP 2%와 5%의 사용을 최초로 승인한 데 따른 것입니다.
시장 기업들은 인수, 제휴, 타사와의 계약과 같은 비유기적 전략에 집중하고 있습니다. 이는 예측 기간 동안 시장 성장을 가속할 것으로 예측됩니다. 예를 들어, 2017년 8월 미국의 바이오 제약 기업인 Aclaris Therapeutics, Inc.는 Confluence Life Sciences, Inc.를 인수했습니다. 이로써 Confluence의 주력 제품 후보물질인 CDD-450, 외용제 야누스 키나아제 억제제, IL2 유도 T세포 키나아제 억제제 프로그램이 추가되어 Aclaris의 염증 및 면역학 분야 파이프라인이 확장되었습니다.
또한, 시장 진출기업들이 연구개발 활동에 집중하고 있는 것은 세계 탈모증 치료제 시장의 성장을 가속할 것으로 예측됩니다. 예를 들어, 2022년 8월, 다국적 제약사 화이자는 원형탈모증 환자를 대상으로 한 ALLEGRO 임상 2b/3상 시험의 양호한 탑라인 결과를 발표하였습니다. 원형탈모증은 모낭에 대한 면역 공격이 특징인 자가면역질환으로 두피의 탈모를 유발할 뿐만 아니라 얼굴과 몸에도 영향을 미칠 수 있습니다.
본 조사의 주요 특징
- 이 보고서는 다양한 부문의 잠재적 수익 창출 기회를 밝히고, 이 시장에서 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 지역별 전망, 주요 기업의 경쟁 전략에 대한 중요한 인사이트도 제공합니다.
- 이 보고서는 기업 개요, 재무 실적, 제품 포트폴리오, 사업 지역, 유통 전략, 주요 개발 및 전략, 향후 계획 등 주요 세계 탈모증 치료제 시장의 주요 기업 프로파일을 작성했습니다.
- 이 보고서의 내용을 통해 기업의 마케팅 담당자와 경영진은 향후 제품 출시, 기술 업그레이드, 시장 확대 및 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있을 것으로 기대됩니다.
- 이 세계 탈모증 치료 시장 보고서는 투자자, 공급업체, 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 탈모증 치료제 시장 분석에 사용되는 다양한 전략 매트릭스를 활용하여 의사결정을 쉽게 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 탈모 치료 시장 : 약제 클래스별, 2021년-2033년
제5장 세계의 탈모 치료 시장 : 질환 유형별, 2021년-2033년
제6장 세계의 탈모 치료 시장 : 투여 경로별, 2021년-2033년
제7장 세계의 탈모 치료 시장 : 유통 채널별, 2021년-2033년
제8장 세계의 탈모 치료 시장 : 지역별, 2021년-2033년
제9장 경쟁 구도
제10장 섹션
LSH 26.06.17Alopecia Treatment Market is estimated to be valued at USD 11.38 Bn in 2026 and is expected to reach USD 16.89 Bn by 2033, growing at a compound annual growth rate (CAGR) of 5.8% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 11.38 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 5.80% | 2033 Value Projection: | USD 16.89 Bn |
Alopecia is the medical term for hair loss. Hair loss can happen naturally or as a result of a disease or the use of certain medications. Some common types of alopecia include
- Androgenic alopecia is common in both men and women. It is also referred to as male- or female-pattern hair loss.
- Alopecia areata- Alopecia areata is also known as patchy baldness. Bald patches can appear anywhere on the body, but the majority of people get a round or oval patch on the scalp.
- Traction alopecia is caused by putting stress on the hair by pulling or stretching it repeatedly
Market Dynamics
Market players are focused on product launches or approvals, which is expected to drive growth of the global alopecia treatment market over the forecast period. For instance, in September 2022, Dr. Reddy's Laboratories Limited announced the launch of Minoxidil topical solution USP 2% and 5% for the treatment of female pattern hair loss (FPHL). Dr. Reddy's will market its products as Mintop 2 percent and Mintop Eva 5 percent, respectively. The launch comes after the Central Drugs Standard Control Organization (CDSCO) in India approved the use of Minoxidil topical solution USP 2% and 5% for the treatment of FPHL for the first time.
Market players are focused on inorganic strategies such as acquisitions, partnerships, and agreements with other market players. This is expected to drive the market growth over the forecast period. For instance, in August 2017, Aclaris Therapeutics, Inc., a biopharmaceutical company based in the U.S. acquired Confluence Life Sciences, Inc., which expanded Aclaris' inflammation and immunology pipeline with the addition of Confluence's lead product candidates CDD-450, topical Janus kinase inhibitors, and IL2-inducible T-cell kinase inhibitor programs.
Moreover, market players are focused on research and development activities is expected to propel the growth of the global alopecia treatment market. For instance, in August 2022, Pfizer Inc., a multinational biopharmaceutical company announced positive top-line results from the Phase 2b/3 ALLEGRO trial, which evaluated oral once-daily ritlecitinib in patients with alopecia areata, an autoimmune disease characterized by an immune attack on hair follicles that causes hair loss on the scalp and can also affect the face and body.
Key features of the study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players.
- It profiles leading players in the global alopecia treatment market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans.
- Key companies covered as a part of this study include Aclaris Therapeutics, Inc., Fagron, Follicum AB, Cipla Inc., Arcutis Biotherapeutics, Dr. Reddy's Laboratories Ltd., Himalaya Wellness Company, Eli Lilly and Company, Concert Pharmaceuticals Inc., and Teva Pharmaceutical Industries Ltd.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics.
- The global alopecia treatment market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision making through various strategy matrices used in analyzing the global alopecia treatment market.
Market Segmentation
- By Drug Class (Revenue, USD Bn, 2021 - 2033)
- Corticosteroids
- 5 AR Inhibitors
- Vasodilators
- Others
- By Disease Type (Revenue, USD Bn, 2021 - 2033)
- Alopecia Areata
- Androgenic Alopecia
- Traction Alopecia
- Others
- By Route of Administration (Revenue, USD Bn, 2021 - 2033)
- Topical
- Oral
- Injectable
- By Distribution Channel (Revenue, USD Bn, 2021 - 2033)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- By Geography (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Stemson Therapeutics
- OliX Pharmaceuticals, Inc.
- Pfizer Inc.
- Aclaris Therapeutics, Inc.
- Fagron, Follicum AB
- Cipla Inc.
- Arcutis Biotherapeutics
- Reddy's Laboratories Ltd.
- Himalaya Wellness Company
- Cosmo Pharmaceuticals N.V.
- Equillium, Inc.
- Eli Lilly and Company
- Concert PharmaceuticIals Inc.
- Teva Pharmaceutical Industries Ltd.
Table of Contents
1. Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Drug Class
- Market Snippet, By Disease Type
- Market Snippet, By Route of Administration
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Recent Trends
- Mergers, Acquisitions, and Collaborations
- Regulatory Scenario
- Key Developments
- PEST Analysis
- PORTER's Analysis
4. Global Alopecia Treatment Market, By Drug Class, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Corticosteroids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Segment Trends
- 5 AR Inhibitors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Segment Trends
- Vasodilators
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Segment Trends
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Segment Trends
5. Global Alopecia Treatment Market, By Disease Type, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Alopecia Areata
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Segment Trends
- Androgenic Alopecia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Segment Trends
- Traction Alopecia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Segment Trends
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Segment Trends
6. Global Alopecia Treatment Market, By Route of Administration, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Topical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Segment Trends
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Segment Trends
- Injectable
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Segment Trends
7. Global Alopecia Treatment Market, By Distribution Channel, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
8. Global Alopecia Treatment Market, By Region, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- North America
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 -2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 -2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- U.S.
- Canada
- Europe
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 -2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 -2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 -2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 -2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 -2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 -2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 -2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 -2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 -2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 -2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2021 - 2033, (USD Bn)
- North Africa
- Central Africa
- South Africa
9. Competitive Landscape
- Company Profiles
- Stemson Therapeutics
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- OliX Pharmaceuticals
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Pfizer Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Aclaris Therapeutics
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Fagron,
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Follicum AB
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Cipla Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Arcutis Biotherapeutics
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Dr. Reddy's Laboratories Ltd.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Himalaya Wellness Company
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Cosmo Pharmaceuticals N.V.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Equillium, Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Eli Lilly and Company
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Concert Pharmaceuticals Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Teva Pharmaceutical Industries Ltd.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Stemson Therapeutics
- Analysts' Views
10. Section
- References
- Research Methodology
- About Us and Sales Contact
